1. Home
  2. NBY vs BWAY Comparison

NBY vs BWAY Comparison

Compare NBY & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.45

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$12.64

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
BWAY
Founded
2000
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
450.8M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
NBY
BWAY
Price
$1.45
$12.64
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.25
AVG Volume (30 Days)
1.2M
84.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.42
N/A
EPS
0.76
N/A
Revenue
$370,000.00
N/A
Revenue This Year
$23.91
$314.08
Revenue Next Year
$32.05
$23.37
P/E Ratio
$1.94
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$7.84
52 Week High
$19.95
$26.63

Technical Indicators

Market Signals
Indicator
NBY
BWAY
Relative Strength Index (RSI) 43.99 22.30
Support Level $0.58 $11.44
Resistance Level $2.66 $17.20
Average True Range (ATR) 0.26 1.34
MACD 0.27 -1.28
Stochastic Oscillator 44.20 4.61

Price Performance

Historical Comparison
NBY
BWAY

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: